The Reminder is making its archives back to 2003 available on our website. Please note that, due to technical limitations, archive articles are presented without the usual formatting.
The Canadian cancer society (CCS) has issued a news release regarding their findings on the use of HRT (combined hormone replacement therapy). They have stated that due to increased risk of getting cancer, women should avoid the use of this treatment for any reason other than to relieve severe menopausal symptoms, and all other methods of treatment have failed. The research done by the CCS shows "that long-term use of HRT increases the risk of breast cancer in women over 50 years as well as increases the risk of other disease including heart disease, stroke and blood clots in the lungs. Current evidence shows that the risks of HRT use outweigh the potential benefits". Women who are experiencing severe menopausal symptoms should consult their doctor basing the decision on the risks and benefits of taking this drug treatment. Consideration should include: the woman's individual and family history of breast and ovarian cancer as well as heart disease, osteoporosis and dementia. Also how severe are the menopausal symptoms as well as how long the treatment will last. A thorough review of the research led the CCS to develop its recommendations. "What we are saying, based on current research, is that if a woman and her doctor decide that taking HRT is right for this particular woman, it should be used for the shortest time possible to control the symptoms for which it was started". The CCS is a national community based organization of volunteers whose mission is to eradicate cancer and to improve the life of people who are living with cancer. For further information call 1-888-939-3333 or go to www.cancer.ca
